arrow
P

Pranav Shah

national institutes of health
H指数:23
被引数:1,483

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling

新型5-苯基吗啡烷作为阿片受体拮抗剂:合成、构效关系、生物评价和计算建模

2026-10-020
OA
Structure–Activity Relationship Studies toward the Optimization of First-In-Class Selective Small Molecule Agonists of the GPCR Relaxin/Insulin-like Family Peptide Receptor 2

结构-活性关系研究以优化首创新药选择性小分子激动剂,针对GPCR松弛素/胰岛素样家族肽受体2

2026-02-190
PRE
IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia

IRAK1/4/pan-FLT3激酶抑制剂,具有降低的hERG阻断作用,作为急性髓系白血病的治疗方法

2025-04-290
PRE
Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia
2024-10-231
OAAI
In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis

Hermansky-pudlak综合征肺纤维化的候选药物S-MRI-1867的体外和体内药代动力学表征,手性转化和PBPK缩放

2023-12-011
OAAI
Prevalence and Causes of Diagnostic Errors in Hospitalized Patients Under Investigation for COVID-19
2023-03-237
OAAI
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis
2022-06-138
OA
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites
2021-01-2220
OAAI